Nanocarriers for photodynamic-gene therapy

Area of Science:

• Nanomedicine
• Biotechnology
• Oncology

Background:

• Conventional cancer monotherapies have limitations.
• Nanomedicine offers improved therapeutic outcomes through synergistic effects.
• Gene therapy (GT) and photodynamic therapy (PDT) are promising alternative anticancer strategies.

Purpose of the Study:

• To review strategies combining photodynamic therapy (PDT) and gene therapy (GT) for cancer treatment.
• To discuss the role of nanocarriers (nonviral vectors) in enhancing PDT and GT synergy.
• To explore nanomaterial design, responsiveness, biological interactions, and anticancer performance.

Main Methods:

• Literature review of combined PDT and GT strategies.
• Analysis of nanocarrier roles in synergistic cancer therapy.
• Examination of in vitro and in vivo studies on nanomedicine performance.

Main Results:

• Combination of PDT and GT using nanocarriers demonstrates synergistic anticancer effects.
• Nanocarrier design influences drug delivery, targeting, and therapeutic efficacy.
• Studies show promising in vitro and in vivo anticancer performance of these combined strategies.

Conclusions:

• Nanomedicine-enabled combinations of PDT and GT represent a potent anticancer strategy.
• Optimized nanocarrier systems are crucial for maximizing therapeutic synergy.
• Further research into nanocarrier-mediated PDT-GT combinations holds significant therapeutic potential.